跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,067 条关于
“Nanjing Chia Tai Tianqing”
全部
10,067
临床试验
6,147
药物
987
机构
239
资讯
2,694
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease
去年
Algeria Approves Sino Biopharmaceutical's Adalimumab Biosimilar for Autoimmune Disease Treatment
9个月前
Novel Astatine-211 Targeted Alpha Therapy Shows Promise for Radioactive Iodine-Refractory Thyroid Cancer
去年
Advanced Renal Cell Carcinoma Pipeline Shows Strong Growth with 60+ Therapies in Development
5个月前
SBP Group's M701 Bispecific Antibody Receives NDA Acceptance for Malignant Ascites Treatment
去年
Inventiva Restructures: Halves Workforce to Focus on Late-Stage MASH Drug Lanifibranor
去年
Inventiva Secures €348 Million to Advance Lanifibranor Phase III Trial for MASH
18天前
Cipla Secures Exclusive Rights to HER2 Bispecific ADC TQB2102 Across Seven Emerging Markets
3个月前
Sino Biopharm's TQC2938 Becomes First ST2 Antibody to Show Positive Phase II Results in Allergic Rhinitis
2年前
Anlotinib and Penpulimab Combination Shows Promise in Advanced Hepatocellular Carcinoma
第 1 页,共 270 页
上一页
下一页